Jerome Galon from partner INSERM received the William B. Coley Award for "Distinguished Research in Basic and Tumor Immunology"
Prof. Klaus Pantel from partner UKE wins the "Deutscher Krebspreis" (German Cancer Award)
GENINCA (GENomic INstability and genomic alterations in pre-cancerous lesions and/or CAncer) aims at developing new diagnostic tools and treatment options for both liver and colon cancer. This project will employ a unique spectrum of cutting-edge technologies to characterize in detail very early lesions, e.g. adenomas, their microenvironment and other factors, which may predispose individuals to develop tumors. GENINCA represents a collaborative study of 8 academic and 3 industrial partners from 5 European countries and is coordinated by the Institute of Human Genetics at the Medical University of Graz.
Download Fact Sheet in English
Scarica qui informazioni sul progetto in Italiano
Téléchargez des informations sur le projet en Français
Projektdetails auf Deutsch herunterladen
Supported through the EC's 7th Framework Program through Grant Agreement No. HEALTH-F2-2008-202230